3B BlackBio Dx Limited — Investor Relations & Filings

3B BlackBio Dx Limited specializes in the development, manufacturing, and commercialization of advanced molecular diagnostic kits. Operating under the flagship brand TRUPC®, the company provides a comprehensive portfolio of real-time PCR-based assays for oncology, infectious diseases, and human genetics. Key offerings include kits for BCR-ABL quantification, JAK2 mutation detection, and various viral load monitoring tools for HBV, HCV, and HIV. The company is recognized for its development of RT-PCR kits for COVID-19 and H1N1. Its products are designed for high sensitivity and specificity, catering to clinical laboratories and hospitals. 3B BlackBio Dx Limited maintains ISO 13485 certification, ensuring international quality standards in its production processes. The firm focuses on delivering reliable, cost-effective diagnostic solutions to improve patient management and clinical outcomes.